Expert-Agreed Practical Recommendations on the Use of Cladribine

Cladribine is a disease-modifying selective immune reconstitution oral therapy for adult patients with highly active relapsing multiple sclerosis (RMS). It was approved in the USA in 2019 and in Europe in 2017, thus there are still gaps in existing guidelines for using cladribine tablets in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Meca-Lallana, Virginia, García Domínguez, José M., López Ruiz, Rocío, Martín-Martínez, Jesús, Arés Luque, Adrián, Hernández Pérez, Miguel A., Prieto González, José M., Landete Pascual, Lamberto, Sastre-Garriga, Jaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447968/
https://www.ncbi.nlm.nih.gov/pubmed/36068429
http://dx.doi.org/10.1007/s40120-022-00394-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447968/
https://www.ncbi.nlm.nih.gov/pubmed/36068429
http://dx.doi.org/10.1007/s40120-022-00394-0

Ejemplares similares